Cardiff Oncology, Inc. (CRDF) vs MediciNova, Inc. (MNOV)
- Cardiff Oncology, Inc. CRDF 0.91 −6.19%
- MediciNova, Inc. MNOV 1.42 −2.07%
Cardiff Oncology, Inc. and MediciNova, Inc. are both Biotechnology companies. Cardiff Oncology, Inc. and MediciNova, Inc. are of similar size ($75.5M and $71.4M). Cardiff Oncology, Inc. grew revenue faster over the last twelve months: −6.79% against −82.2%. MediciNova, Inc. has the higher net margin (−1,168.3% vs −7,889.0%) and the lower return on invested capital (−62.5% vs 0.00%). Across the 16 metrics below, MediciNova, Inc. leads on 11 and Cardiff Oncology, Inc. on 5.
Valuation
Profitability
| Metric | CRDF | MNOV | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 37.76% | 65.16% |
| Operating margin | (8,320.08%) | (1,287.53%) | 0.00% |
| Net margin | (7,888.98%) | (1,168.31%) | 0.00% |
| Free cash flow margin | (8,059.45%) | (991.31%) | 0.00% |
| Return on equity | (94.14%) | (25.56%) | (56.36%) |
| Return on assets | (70.89%) | (23.83%) | (48.04%) |
| Return on invested capital | 0.00% | (62.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack